ZA933669B - Removal of antibodies from blood-derived compositions while retaining coagulation factors - Google Patents

Removal of antibodies from blood-derived compositions while retaining coagulation factors

Info

Publication number
ZA933669B
ZA933669B ZA933669A ZA933669A ZA933669B ZA 933669 B ZA933669 B ZA 933669B ZA 933669 A ZA933669 A ZA 933669A ZA 933669 A ZA933669 A ZA 933669A ZA 933669 B ZA933669 B ZA 933669B
Authority
ZA
South Africa
Prior art keywords
antibodies
coagulation factors
blood
retaining
removal
Prior art date
Application number
ZA933669A
Other languages
English (en)
Inventor
Bernard Horowitz
Sing N Chin
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Publication of ZA933669B publication Critical patent/ZA933669B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265—Adsorption chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA933669A 1992-05-28 1993-05-26 Removal of antibodies from blood-derived compositions while retaining coagulation factors ZA933669B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89052892A 1992-05-28 1992-05-28

Publications (1)

Publication Number Publication Date
ZA933669B true ZA933669B (en) 1993-12-21

Family

ID=25396801

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933669A ZA933669B (en) 1992-05-28 1993-05-26 Removal of antibodies from blood-derived compositions while retaining coagulation factors

Country Status (10)

Country Link
US (1) US5541294A (de)
EP (1) EP0572194B1 (de)
JP (1) JP3183750B2 (de)
KR (1) KR100273010B1 (de)
AT (1) ATE183098T1 (de)
AU (1) AU667530B2 (de)
CA (1) CA2096654C (de)
DE (1) DE69325948T2 (de)
ES (1) ES2137225T3 (de)
ZA (1) ZA933669B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182195A1 (en) * 1997-08-05 2002-12-05 Octapharma Ag Universally applicable blood plasma
EP0896824A1 (de) * 1997-08-05 1999-02-17 Octapharma Ag Universell verwendbares Bluttplasma
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
NZ513242A (en) * 1999-02-22 2003-10-31 Henry B Kopf Purification of biological substances
EP1209969A2 (de) * 1999-08-31 2002-06-05 RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. Peptide und substanzen sowie verfahren und vorrichtungen, die diese zum diagnostizieren und behandeln neurodegenerativer störungen verwenden
WO2001027623A2 (en) * 1999-10-08 2001-04-19 V.I. Technologies, Inc. Isoagglutinin-depleted blood compositions and methods of making same
US6646287B1 (en) * 1999-11-19 2003-11-11 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device with tapered gate and insulating film
DE60133337T2 (de) * 2000-02-08 2008-07-03 Glycorex Transplantation Ab Oligosaccharidenträger, beispielsweise für die entfernung von antikörpern aus dem blut
DE10016877A1 (de) * 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
EP1272509A2 (de) * 2000-04-05 2003-01-08 V.I. Technologies, Inc. Peptidische bindstoffe für prione und verfahren zu deren verwendung
PT1696940E (pt) * 2003-12-19 2007-05-31 Octapharma Ag Plasma sanguíneo aplicável universalmente, com inactivação de vírus, produzido de porções de plasma não-caucasiano.
KR100791502B1 (ko) * 2006-09-29 2008-01-03 한스바이오메드 주식회사 바이러스 불활화된 무세포 인체 이식재 생산방법
US8449520B2 (en) * 2007-03-19 2013-05-28 HemCon Medical Technologies Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US7776022B2 (en) * 2007-03-19 2010-08-17 Hemcon Medical Technologies Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090107001A1 (en) * 2007-03-19 2009-04-30 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
US20090223080A1 (en) * 2007-03-19 2009-09-10 Hemcon Medical Technologies, Inc. Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma
WO2012075041A2 (en) 2010-11-29 2012-06-07 New York Blood Center, Inc. Method of blood pooling and storage
FR3026950A1 (fr) 2014-10-09 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de plasma universel
FR3035799B1 (fr) 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035794B1 (fr) 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
US10697982B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
DE102020212609B3 (de) * 2020-10-06 2022-04-07 Universität Greifswald Verfahren und Vorrichtung zur Herstellung von Universalplasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
GB1603609A (en) * 1977-04-14 1981-11-25 Chembiomed Ltd O-protected 2-azido-2-deoxy-glycosyl nitrates
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
CH660634A5 (de) * 1983-08-30 1987-05-15 Dimitrios Giannitsis Verfahren zur herstellung von natuerlichem immunoadsorbens.
WO1986005397A1 (en) * 1985-03-13 1986-09-25 Nordisk Gentofte A/S Immunosorbent for removal of rheumatoid factors from whole blood or blood plasma
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
JP2926728B2 (ja) * 1988-12-29 1999-07-28 吉富製薬株式会社 蛋白質含有組成物の製造方法

Also Published As

Publication number Publication date
CA2096654A1 (en) 1993-11-29
EP0572194B1 (de) 1999-08-11
US5541294A (en) 1996-07-30
AU3864793A (en) 1993-12-02
KR100273010B1 (ko) 2001-02-01
ATE183098T1 (de) 1999-08-15
EP0572194A1 (de) 1993-12-01
ES2137225T3 (es) 1999-12-16
JPH06100463A (ja) 1994-04-12
DE69325948D1 (de) 1999-09-16
CA2096654C (en) 2001-02-27
KR930023038A (ko) 1993-12-18
DE69325948T2 (de) 2000-01-20
JP3183750B2 (ja) 2001-07-09
AU667530B2 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
ZA933669B (en) Removal of antibodies from blood-derived compositions while retaining coagulation factors
ATE35905T1 (de) Verfahren zur herstellung keimfreier proteinmischungen.
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
CA2232604A1 (fr) Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
IL100253A0 (en) Nitrogen derivatives
DE69004625D1 (de) Verfahren zur Herstellung von strahlungsvernetzbaren Überzügen, strahlungsvernetzbare Zusammensetzungen und Carbonate.
DE69532137D1 (de) Verbessertes verfahren zur stabilisierung biologischer substanzen während der trocknung und anschliessender lagerung sowie die entsprechenden zusammensetzungen
DE3886845D1 (de) Hochfeste, hitzebeständige Aluminiumlegierungen und Verfahren zur Herstellung von Gegenständen aus diesen Legierungen.
ATE17363T1 (de) Verfahren zur herstellung von hochelastischen schaeumen und alkoxysilicium-verbindung(en) als schaumstabilisatoren hierfuer.
DE59409434D1 (de) Verfahren zur Herstellung von Hydroxyphenyl-1,3,5-Triazinen
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE59402292D1 (de) Verfahren zur Herstellung von 1,3,5-Triazinen
DE69118002D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorchlorethan und 1,1,1,2-Tetrafluorethan
JPS5738716A (en) Incised wound treating composition
DE69300551D1 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
DE69418364D1 (de) Verfahren zur Herstellung von Polybutadienzusammensetzungen
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DE69007245D1 (de) Aminobutanolderivate und Verfahren zur Herstellung von 3-Pyrrolidinol aus diesen.
DE68917817D1 (de) Verfahren zur Herstellung von vernetzten Polycarbonaten und Zusammensetzungen daraus.
EP1107789A4 (de) Zusammensetzungen und verfahren zum schutz von organen, gewebe und zellen vor schäden, die durch das immunsystem verursacht werden
DE59300777D1 (de) Verfahren zur Herstellung von Perfluorpolyethern.
HUP0003610A1 (hu) Eljárás biológiai anyag virális és molekuláris kórokozótartalmának gyérítésére
DE69934057D1 (de) Verfahren zur Behandlung von Alkylamino (Meth)Acrylaten
DE69014501D1 (de) Verfahren zur Behandlung von Titanlegierung und damit hergestelltes Stück.